Market Research Reports- Consulting Analysis Crystal Market Research Bioabsorbable Stents Market | Page 2
attacks in certain cases. Peripheral artery diseases can be attributed to narrowing of the peripheral arteries
to the arms, legs, and stomach. Atherosclerosis is one of the prime reasons for the induction of peripheral
artery diseases. If left untreated, these diseases can lead to gangrene requiring amputation of the body
part.
North America held the major share of the bioabsorbable stents market in 2016 with the U.S. representing
the largest market, followed by Canada. Sedentary lifestyle habits of people have resulted in rise of
cardiovascular disorders in the region. Rising awareness about the utility of bioabsorbable stents for
treating coronary diseases along with technological advancements in these stents have contributed to the
growth of this regional market. For instance, in 2016, Abbott obtained FDA approval for its Absorb
bioabsorbable stent, which is the only fully dissolvable stent approved for the treatment of coronary artery
disorders. Asia-Pacific market is anticipated to show a higher growth rate over the forecast period with
the improving healthcare infrastructure in emerging nations as well as growing disposable income of
people.
Request a sample copy of Bioabsorbable Stents Market Research Report @
http://www.crystalmarketresearch.com/report-sample/HC0510
The leading companies in bioabsorbable stents market focus on collaborations and agreements to ensure
and further enhance their share in the market. Some key players in bioabsorbable stents market are
Biotronik, Medtronic plc, Kyoto Medical Planning. Co. Ltd, Reva Medical, Microport Scientific
Corporation, Elixir Medical Corporation, Terumo Europe NV, and Boston Scientific corporation.
Key Findings of the Research Study:
Polymeric bioabsorbable stents are widely used in treating cardiovascular diseases which can
reduce the chances of thrombotic events.
Coronary artery disease market is a promising segment expected to show high growth rate from
2017 to 2025, as bioabsorbable stents play crucial role in the treatment of coronary artery
diseases.
North America was the largest bioabsorbable stents market for in 2016, due to consistent
technological advancements in these stents due to developed healthcare infrastructure.
Asia-Pacific market will exhibit a high CAGR during the forecast period, due to presence of high
unmet medical needs, rising disposable income of patients, and the constantly improving
healthcare infrastructure.
Japan accounted for the major share of the Asia-Pacific market in 2016, while China is projected
to be the fastest growing country over the forecast period.
Inquire more about this report at: http://www.crystalmarketresearch.com/send-an-
enquiry/HC0510